Kane Biotech Inc
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface pol… Read more
Kane Biotech Inc (KNBIF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.781x
Based on the latest financial reports, Kane Biotech Inc (KNBIF) has a cash flow conversion efficiency ratio of 0.781x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-538.12K) by net assets ($-688.65K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kane Biotech Inc - Cash Flow Conversion Efficiency Trend (2014–2022)
This chart illustrates how Kane Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Kane Biotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kane Biotech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gyrodyne Company of America Inc
NASDAQ:GYRO
|
0.000x |
|
Pilot Energy Ltd
AU:PGY
|
-0.287x |
|
Nitiraj Engineers Limited
NSE:NITIRAJ
|
-0.097x |
|
Eonmetall Group Bhd
KLSE:7217
|
-0.009x |
|
Methanor
PA:ALMET
|
13.794x |
|
Pacific Ridge Exploration Ltd
OTCQB:PEXZF
|
-0.506x |
|
Seko S.A.
WAR:SEK
|
0.057x |
|
Kun Peng International Ltd.
OTCQB:KPEA
|
0.034x |
Annual Cash Flow Conversion Efficiency for Kane Biotech Inc (2014–2022)
The table below shows the annual cash flow conversion efficiency of Kane Biotech Inc from 2014 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-4.14 Million | $-3.04 Million | 0.736x | -49.65% |
| 2021-12-31 | $-1.57 Million | $-2.29 Million | 1.461x | +139.86% |
| 2020-12-31 | $1.07 Million | $-3.94 Million | -3.665x | -246.40% |
| 2019-12-31 | $836.81K | $-885.37K | -1.058x | -137.02% |
| 2018-12-31 | $-984.84K | $-2.81 Million | 2.858x | +488.18% |
| 2017-12-31 | $2.74 Million | $-2.02 Million | -0.736x | +58.02% |
| 2016-12-31 | $1.35 Million | $-2.36 Million | -1.754x | +39.34% |
| 2015-12-31 | $480.25K | $-1.39 Million | -2.891x | -265.11% |
| 2014-12-31 | $11.07K | $-8.77K | -0.792x | -- |